Evidence map›Paper›PMID 40897917›Full record

ReviewNature reviews. Urology2026

The current landscape of single-port robotic surgery in urology.

Arianna Biasatti, Nicolas A Soputro, Francesco Porpiglia, Sisto Perdonà, Firas Abdollah, Ryan Nelson, Craig Rogers, Lee C Zhao, Ahmed Ghazi, Ben Challacombe and 49 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

59 authors.

Arianna Biasatti *Department of Urology, Rush University Medical Center, Chicago, IL, USA.
Nicolas A Soputro *Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
Francesco PorpigliaDepartment of Oncology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Italy.
Sisto PerdonàIstituto Nazionale Tumori di Napoli, IRCCS "Fondazione G. Pascale", Naples, Italy.
Firas AbdollahVattikuti Urology Institute, Henry Ford Hospital, Detroit, MI, USA.
Ryan NelsonMichigan Institute of Urology, Detroit, MI, USA.
Craig RogersVattikuti Urology Institute, Henry Ford Hospital, Detroit, MI, USA.
Lee C ZhaoDepartment of Urology, NYU Langone Health, New York, NY, USA.ORCID 0000-0002-4029-0669
Ahmed GhaziBrady Urological Institute, Johns Hopkins University, Baltimore, MD, USA.
Ben ChallacombeDepartment of Urology, London Bridge Hospital, London, UK.
Christopher EdenDepartment of Urology, Royal Surrey County Hospital, Guildford, UK.
Agostino MatteiDepartment of Urology, University of Lucerne, Lucerne, Switzerland.
Christian D FankhauserDepartment of Urology, University of Lucerne, Lucerne, Switzerland.
Alberto BredaDepartment of Urology, Fundació Puigvert, Autonomous University of Barcelona, Barcelona, Spain.
Bernardo RoccoIRCCS A. Gemelli University Polyclinic Foundation, Sacred Heart Catholic University, Rome, Italy.
Francesco MontorsiDivision of Experimental Oncology/Unit of Urology; URI; IRCCS Ospedale San Raffaele, Milan, Italy.
Alberto BrigantiDivision of Experimental Oncology/Unit of Urology; URI; IRCCS Ospedale San Raffaele, Milan, Italy.
Antony A PellegrinoDivision of Experimental Oncology/Unit of Urology; URI; IRCCS Ospedale San Raffaele, Milan, Italy.ORCID 0000-0002-0898-1953
Alexandre MottrieDepartment of Urology, Azorg Hospital, Aalst, Belgium; ORSI Academy, Ghent, Belgium.
Ruben De GrooteDepartment of Urology, Azorg Hospital, Aalst, Belgium; ORSI Academy, Ghent, Belgium.
Alexander HaeseMartini-Klinik Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Markus GraefenMartini-Klinik Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Marcio C MoschovasAdventHealth Global Robotics Institute, Celebration, USA; University of Central Florida, Orlando, FL, USA.
Vipul PatelAdventHealth Global Robotics Institute, Celebration, USA; University of Central Florida, Orlando, FL, USA.
Giuseppe SimoneUro-Oncology Program, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.ORCID 0000-0002-4868-9025
Antonio GalfanoDepartment of Urology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.ORCID 0000-0002-2656-5531
Silvia SeccoDepartment of Urology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Riccardo BertoloDepartment of Urology, University of Verona, A.O.U.I., Verona, Italy.ORCID 0000-0003-0260-4601
Savio D PandolfoDepartment of Urology, University of L'Aquila, L'Aquila, Italy.
Vito PansadoroVincenzo Pansadoro Foundation, Rome, Italy.
Filipe L F CarvalhoDepartment of Urology, Brigham and Women's Hospital, Boston, MA, USA.
Jean V JosephDepartment of Urology, University of Rochester Medical Center, Rochester, NY, USA.
Mohammad RamadanDepartment of Urology, SSM Health St. Anthony Hospital, Oklahoma City, OK, USA.
Jaschar Shakuri-RadDepartment of Urology, Mon Health Medical Center, Morgantown, WV, USA.
Bertram YuhDepartment of Urology, City of Hope, Duarte, CA, USA.
Jeffrey NixDepartment of Urology, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL, USA.
David I LeeDepartment of Urology, University of California Irvine, Irvine, CA, USA.
Soroush Rais-BahramiDepartment of Urology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.ORCID 0000-0001-9466-9925
Sij HemalUSC Norris Comprehensive Cancer Center, Institute of Urology, Keck School of Medicine of University of Southern California, Los Angeles, CA, USA.
Mohamed EltemamyDepartment of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
Alp T BeksacDepartment of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.ORCID 0000-0001-6742-0040
Zeyad SchwenDepartment of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
Li-Ming SuDepartment of Urology, University of Florida, Gainesville, FL, USA.
Maurizio BuscariniDepartment of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Michael PaleseDepartment of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Ash TewariDepartment of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0002-3146-4524
Peter WiklundDepartment of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Edward E CherulloDepartment of Urology, Rush University Medical Center, Chicago, IL, USA.
Srinivas VourgantiDepartment of Urology, Rush University Medical Center, Chicago, IL, USA.
Jennifer A LinehanDepartment of Urology and Urologic Oncology, Saint John's Cancer Institute at Providence Saint John's Health Center, Santa Monica, CA, USA.
Zhenjie WuDepartment of Urology, Changhai Hospital, Naval Medical University, Shanghai, China.
Michael StifelmanDepartment of Urology, Hackensack Meridien Health, Hackensack, NJ, USA.
Mutahar AhmedDepartment of Urology, Hackensack Meridien Health, Hackensack, NJ, USA.
Reza MehrazinDepartment of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Ketan BadaniDepartment of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Richard E LinkScott Department of Urology, Baylor College of Medicine, Houston, TX, USA.
Simone CrivellaroDepartment of Urology, University of Illinois at Chicago Health, Chicago, IL, USA.
Jihad KaoukDepartment of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.ORCID 0000-0002-7127-6069
Riccardo AutorinoDepartment of Urology, Rush University Medical Center, Chicago, IL, USA. ricautor@gmail.com.ORCID 0000-0001-7045-7725

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The advent of the purpose-built da Vinci single-port robotic platform marks a pivotal advancement in minimally invasive urological surgery. Designed to overcome the ergonomic and technical limitations of prior single-site approaches, the single-port system enables complex procedures through a single incision, with enhanced dexterity, optimized use of confined spaces and improved cosmetic and peri-operative outcomes. The single-port system has been increasingly used across a wide range of urological indications, including robot-assisted radical prostatectomy, partial nephrectomy, nephroureterectomy and reconstructive surgeries such as pyeloplasty and ureteral re-implantation. Innovative access strategies, such as the single-port transvesical and low anterior access approaches, have facilitated regionalized and multi-quadrant surgeries without the need for repositioning or robot re-docking. These advances have translated into reduced morbidity, faster recovery and increased feasibility of opioid-sparing, same-day discharge protocols. As surgical expertise deepens and technology evolves, the single-port robotic platform stands as a refinement of minimally invasive surgery, and also as a potential paradigm shift in urological practice.

Indexed as

Robotic Surgical ProceduresUrologic Surgical ProceduresHumansMinimally Invasive Surgical ProceduresProstatectomy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.